 This study will compare the proportion of patients who have wound closure within 12 weeks as well as the time to wound closure in patients receiving ArtacentTM versus standard of care for treatment of non-healing lower extremity wounds. The recurrence of healed wounds will be assessed at 6 months via a telephone survey 